Use of laser scanning cytometry to study tumor microenvironment

Histology and Histopathology

Volumn 18, Issue 2, 2003, Pages 609-615

  Mocellin, S ^b   Wang, E ^a   Panelli, M ^a   Rossi, C R ^c   Marincola, Francesco M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c NONE

Author keywords

Laser scanning cytometry; Tumor biology

Indexed keywords

CANCER VACCINE; IMMUNOMODULATING AGENT; INTERLEUKIN 2;

APOPTOSIS; BREAST CANCER; CANCER IMMUNOTHERAPY; CELL LEVEL; CYTOMETRY; DNA CONTENT; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LASER SCANNING CYTOMETRY; LEUKEMIA; LYMPHOMA; MEDICAL TECHNOLOGY; MELANOMA; METASTASIS; MICROENVIRONMENT; MORPHOLOGY; PHENOTYPE; PROTEIN EXPRESSION; RELIABILITY; REVIEW; TUMOR CELL; VACCINATION;

ANIMALS; APOPTOSIS; DNA, NEOPLASM; HUMANS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; LASERS; NEOPLASMS; PHENOTYPE;

EID: 0037378899     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Abdel-Moneim I., Melamed M. R., Darzynkiewicz Z. and Gorczyca W. (2000). Proliferation and apoptosis in solid tumors. Analysis by laser scanning cytometry. Anal. Quant. Cytol. Histol. 22, 393-397.
2. Bacso Z., Everson R. B. and Eliason J. F. (2000). The DNA of annexin V-binding apoptotic cells is highly fragmented. Cancer Res. 60, 4623-4628.
3. Bedner E., Li X., Gorczyca W., Melamed M. R. and Darzynkiewicz Z. (1999). Analysis of apoptosis by laser scanning cytometry. Cytometry 35, 181-195.
4. Bedner E., Li X., Kunicki J. and Darzynkiewicz Z. (2000a). Translocation of Bax to mitochondria during apoptosis measured by laser scanning cytometry. Cytometry 41, 83-88.
5. Bedner E., Smolewski P., Amstad P. and Darzynkiewicz Z. (2000b). Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): Correlation with DNA fragmentation. Exp. Cell Res. 259, 308-313.
6. Buse P., Tran S.H., Luther E., Phu P.T., Aponte G.W. and Firestone G.L. (1999). Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells. A novel convergence point of anti-proliferative and proliferative cell signaling pathways. J. Biol. Chem. 274, 7253-7263.
7. Clatch R.J., Walloch J.L., Zutter M.M. and Kamentsky L.A. (1996). Immunophenotypic analysis of hematologic malignancy by laser scanning cytometry. Am. J. Clin. Pathol. 105, 744-755.
8. Clatch R.J. and Walloch J.L. (1997). Multiparameter immunophenotypic analysis of fine needle aspiration biopsies and other hematologic specimens by laser scanning cytometry. Acta Cytol. 41, 109-122.
9. Clatch R.J., Walloch J.L., Foreman J.R. and Kamentsky L.A. (1997). Multiparameter analysis of DNA content and cytokeratin expression in breast carcinoma by laser scanning cytometry. Arch. Pathol. Lab. Med. 121, 585-592.
10. Clatch R.J. and Foreman J.R. (1998). Five-color immunophenotyping plus DNA content analysis by laser scanning cytometry. Cytometry 34, 36-38.
11. Clatch R.J., Foreman J.R. and Walloch J.L. (1998). Simplified immunophenotypic analysis by laser scanning cytometry. Cytometry 34, 3-16.
12. Cormier J.N., Hijazi Y.M., Abati A., Fetsch P., Bettinotti M., Steinberg S.M., Rosenberg S.A. and Marincola F.M. (1998). Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int. J. Cancer 75, 517-524.
13. Darzynkiewicz Z. and Bedner E. (2000). Analysis of apoptotic cells by flow and laser scanning cytometry. Methods Enzymol. 322, 18-39.
14. Darzynkiewicz Z., Bedner E., Li X., Gorzyca W. and Melamed M.R. (1999). Laser-scanning cytometry: A new instrumentation with many applications. Exp. Cell Res. 249, 1-12.
15. Decker D., Stratmann H., Springer W., Schwering H., Varnai N. and Bollmann R. (1998). Benign and malignant cells in effusions: Diagnostic value of image DNA cytometry in comparison to cytological analysis. Pathol. Res. Pract. 194, 791-795.
16. Ercoli A., Battaglia A., Raspaglio G., Fattorossi A., Alimonti A., Petrucci F., Caroli S., Mancuso S. and Scambia G. (2000). Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: Cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis induction. Int. J. Cancer 85, 98-103.
17. Fattorossi A., BattagliaA., MaggianoN., Malinconico P., Andreocci L., Mancuso S. and Scambia G. (2000). Laser scanning cytometry can complement the flow cytometric DNA analysis in paraffin-embedded cancer samples: A paradigmatic case. Cytometry 42, 123-125.
18. Ferrone S. and Marincola F.M. (1995). Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance. Immunol. Today 16, 487-494.
19. Friedlander M.L., Russell P., Taylor I.W., Hedley D.W. and Tattersall M.H. (1984). Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology 16, 301-306.
20. Furuya T., Uchiyama T., Murakami T., Adachi A., Kawauchi S., Oga A., Hirano T. and Sasaki K. (2000). Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers. Clin. Cancer Res. 6, 2815-2820.
21. Gniadecki R. (2000). Lack of membrane expression of interleukin-2 receptor alpha chain (CD25) in mycosis fungoides: Application of laser scanning cytometry for phenotyping of skin infiltrating lymphocytes. J. Invest. Dermatol. 114, 594-595.
22. Godlewski M.M., Motyl M.A., Gajkowska B., Wareski P., Koronkiewicz M. and Motyl T. (2001). Subcellular redistribution of BAX during apoptosis induced by anticancer drugs. Anticancer Drugs 12, 607-617.
23. Gorczyca W., Bedner E., Burfeind P., Darzynkiewicz Z. and Melamed M.R. (1998a). Analysis of apoptosis in solid tumors by laser-scanning cytometry. Mod. Pathol. 11, 1052-1058.
24. Gorczyca W., Davidian M., Gherson J., Ashikari R., Darzynkiewicz Z. and Melamed M.R. (1998b). Laser scanning cytometry quantification of estrogen receptors in breast cancer. Anal. Quant. Cytol. Histol. 20, 470-476.
25. Gorczyca W., Deptala A., Bedner E., Li X., Melamed M.R. and Darzynkiewicz Z. (2001). Analysis of human tumors by laser scanning cytometry. Methods Cell Biol. 64, 421-443.
26. Harada K., Nishizaki T., Kubota H., Suzuki M. and Sasaki K. (2001). Distinct primary central nervous system lymphoma defined by comparative genomic hybridization and laser scanning cytometry. Cancer Genet. Cytogenet. 125, 147-150.
27. Harada K., Nishizaki T., Ozaki S., Kubota H., Ito H. and Sasaki K. (1998). Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res. 58, 4694-4700.
28. Hashimoto Y., Oga A., Okami K., Imate Y., Yamashita Y. and Sasaki K. (2000). Relationship between cytogenetic aberrations by CGH coupled with tissue microdissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma. Cytometry 40, 161-166.
29. Juan G. and Cordon-Cardo C. (2001). Intranuclear compartmentalization of cyclin E during the cell cycle: Disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. Cancer Res. 61, 1220-1226.
30. Kakino S., Sasaki K., Kurose A. and Ito H. (1996). Intracellular localization of cyclin B1 during the cell cycle in glioma cells. Cytometry 24, 49-54.
31. Kamada T., Sasaki K., Tsuji T., Todoroki T., Takahashi M. and Kurose A. (1997). Sample preparation from paraffin-embedded tissue specimens for laser scanning cytometric DNA analysis. Cytometry 27, 290-294.
32. Kamentsky L.A. and Kamentsky L.D. (1991). Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data. Cytometry 12, 381-387.
33. Kamentsky L.A., Burger D.E., Gershman R.J., Kametsky L.D. and Luther E. (1997a). Slide-based laser scanning cytometry. Acta Cytol. 41, 123-143.
34. Kamentsky L.A., Kamentsky L.D., Fletcher J.A., Kurose A. and Sasaki K. (1997b). Methods for automatic multiparameter analysis of fluorescence in situ hybridized specimens with a laser scanning cytometer. Cytometry 27, 117-125.
35. Kamiya N., Yokose T., Kiyomatsu Y., Fahey M.T., Kodama T. and Mukai K. (1999). Assessment of DNA content in formalin-fixed, paraffin-embedded tissue of lung cancer by laser scanning cytometer. Pathol. Int. 49, 695-701.
36. Kammula U.S., Lee K.H., Riker A.I., Wang E., Ohnmacht G.A., Rosenberg S.A. and Marincola F.M. (1999). Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J. Immunol. 163, 6867-6875.
37. Kammula U.S., Marincola F.M. and Rosenberg S.A. (2000). Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination. J. Natl. Cancer Inst. 92, 1336-1344.
38. Kawamura K., Tanaka T., Ikeda R., Fujikawa-Yamamoto K. and Suzuki K. (2000). DNA ploidy analysis of urinary tract epithelial tumors by laser scanning cytometry. Anal. Quant. Cytol. Histol. 22, 26-30.
39. Li X., Melamed M.R. and Darzynkiewicz Z. (1996). Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color. Exp. Cell Res. 222, 28-37.
40. Martin-Reay D.G., Kamentsky L.A., Weinberg D.S., Hollister K.A. and Cibas E.S. (1994). Evaluation of a new slide-based laser scanning cytometer for DNA analysis of tumors. Comparison with flow cytometry and image analysis. Am. J. Clin. Pathol. 102, 432-438.
41. Miyazaki M., Furuya T., Shiraki A., Sato T., Oga A. and Sasaki K. (1999). The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers. Cancer Res. 59, 5283-5285.
42. Mocellin S., Ohnmacht G.A., Wang E. and Marincola F.M. (2001a). Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness. Int. J. Cancer 93, 236-242.
43. Mocellin S., Fetsch P., Abati A., Phan G.Q., Wang E., Provenzano M., Stroneck D., Rosenberg S.A. and Marincola F.M. (2001). Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases. J. Immunother. 24, 447-458.
44. Pachmann K., Heiss P., Demel U. and Tilz G. (2001). Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC). Clin. Chem. Lab. Med. 39, 811-817.
45. Pilch H., Gunzel S., Schaffer U., Tanner B. and Heine M. (2000). Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging. Cancer 88, 1370-1377.
46. Rew D.A., Woltmann G. and Wardlaw A.J. (1999). Laser-scanning cytometry. Lancet 353, 255-256.
47. Riker A.I., Panelli M.C., Kammula U.S., Wang E., Wunderlich J., Abati A., Fetsch P., Rosenberg S.A. and Marincola F.M. (1999). Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: Advances in the monitoring of patients with metastatic melanoma. Cancer Detect. Prev. 23, 387-396.
48. Rosenberg S.A., Yang J.C., Schwartzentruber D.J., Hwu P., Marincola F.M., Topalian S.L., Restifo N.P., Dudley M.E., Schwartz S.L., Spiess P.J., Wunderlich J.R., Parkhurst M.R., Kawakami Y., Seipp C.A., Einhorn J.H. and White D.E. (1998). Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4, 321-327.
49. Sasaki K., Kurose A., Miura Y., Sato T. and Ikeda E. (1996). DNA ploidy analysis by laser scanning cytometry (LSC) in colorectal cancers and comparison with flow cytometry. Cytometry 23, 106-109.
50. Teodori L., Capurso L., Cordelli E., De Vita R., Koch M., Tarquini M., Pallone F. and Mauro F. (1984). Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions. Cytometry 5, 63-70.
51. Tsukazaki Y., Numa Y., Zhao S. and Kawamoto K. (2000). Analysis of DNA-ploidy using laser scanning cytometer in brain tumors and its clinical application. Hum. Cell 13, 221-228.
52. Vogt T., Stolz W., Hohenleutner U., Schiffner R. and Landthaler M. (1995). Prognostic significance of DNA cytometry in comparison with histologic measurements in malignant melanomas. Recent Results Cancer Res. 139, 195-204.
53. Walle A.J. and Niedermayer W. (1985). Aneuploidy as a marker of minimal residual disease in leukemia. Cancer Detect. Prev. 8, 303-315.
54. Wang E. and Marincola F.M. (2000). A natural history of melanoma: Serial gene expression analysis. Immunol. Today 21, 619-623.
55. Wang E., Miller L.D., Ohnmacht G.A., Liu E.T. and Marincola F.M. (2000). High-fidelity mRNA amplification for gene profiling. Nat. Biotechnol. 18, 457-459.
56. Wang E., Miller L.D., Ohnmacht G.A., Mocellin S., Perez-Diez A., Petersen D., Zhao Y., Simon R., Powell J.I., Asaki E., Alexander H.R., Duray P.H., Herlyn M., Restifo N.P., Liu E.T., Rosenberg S.A. and Marincola F.M. (2002). Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res. 62, 3581-3586.
57. Wojcik E.M., Saraga S.A., Jin J.K. and Hendricks J.B. (2001). Application of laser scanning cytometry for evaluation of DNA ploidy in routine cytologic specimens. Diagn. Cytopathol. 24, 200-205.
58. Zabaglo L., Ormerod M.G. and Dowsett M. (2000). Measurement of markers for breast cancer in a model system using laser scanning cytometry. Cytometry 41, 166-171.